Physical
October 2024 | PM-GB-RS-WCNT-200028 (v3.0)
Ellipta demonstration device
Demonstration device for healthcare professionals to show patients how to use the Ellipta device correctly.
Physical
October 2024 | PM-GB-RS-WCNT-200035 (v4.0)
Ellipta Inhalation Trainer
Training whistle that helps patients understand the correct inspiratory flow needed to use the Ellipta device.
Physical
March 2025 | PM-GB-MPL-WCNT-240010 (V2.0)
Nucala (mepolizumab) patient information booklet
For patients with severe refractory eosinophilic asthma, prescribed Nucala 100 mg prefilled syringe/pen.
Physical
August 2024 | PM-GB-SGX-WCNT-240018 (V2.0)
SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted) Patient Information Leaflet
A printed patient information leaflet for SHINGRIX patients (1 pack = 10 leaflets).
Physical
August 2024 | PM-GB-SGX-WCNT-210017 (V3.0)
SHINGRIX (herpes zoster vaccine, recombinant, adjuvanted) Vaccination Reminder Card
A patient support item to be provided by HCPs when patients receive their 1st dose of Shingrix (1 pack = 50 cards).
Digital
November 2024 | PM-GB-FVU-WCNT-240023 (V1.0)
Trelegy Ellipta (fluticasone furoate/ umeclidinium/ vilanterol) patient information booklet
Support booklet for patients who have been prescribed Trelegy Ellipta.
Physical
January 2025 | PM-GB-RS-WCNT-240010 (V1.0)
Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) Patient Support Pack
Support pack for patients who have been prescribed Trelegy Ellipta
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellowcard in the Google Play or Apple App Store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com.